tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Avidity Biosciences price target raised to $65 from $56 at BofA
PremiumThe FlyAvidity Biosciences price target raised to $65 from $56 at BofA
4d ago
Avidity Biosciences Announces Major Stock Offering
Premium
Company Announcements
Avidity Biosciences Announces Major Stock Offering
6d ago
Avidity Biosciences price target raised to $87 from $68 at H.C. Wainwright
Premium
The Fly
Avidity Biosciences price target raised to $87 from $68 at H.C. Wainwright
6d ago
Avidity Biosciences: Promising Outlook for DMD Treatment with Del-Zota and Platform Expansion
PremiumRatingsAvidity Biosciences: Promising Outlook for DMD Treatment with Del-Zota and Platform Expansion
7d ago
Avidity Biosciences price target raised to $56 from $54 at BofA
Premium
The Fly
Avidity Biosciences price target raised to $56 from $54 at BofA
7d ago
Avidity Biosciences
Premium
The Fly
Avidity Biosciences
8d ago
Avidity Biosciences: Promising Phase 1/2 Trial Results and FDA Agreement Boost Buy Rating
PremiumRatingsAvidity Biosciences: Promising Phase 1/2 Trial Results and FDA Agreement Boost Buy Rating
8d ago
Avidity del-zota data ‘highly encouraging,’ says Cantor Fitzgerald
Premium
The Fly
Avidity del-zota data ‘highly encouraging,’ says Cantor Fitzgerald
8d ago
Avidity Biosciences Amends Share Plan Amid Trial Success
Premium
Company Announcements
Avidity Biosciences Amends Share Plan Amid Trial Success
8d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100